Clinical Trials Logo

Borderline Personality Disorders clinical trials

View clinical trials related to Borderline Personality Disorders.

Filter by:
  • None
  • Page 1

NCT ID: NCT05972096 Recruiting - BPD Clinical Trials

DBT Skills Expanded With Contextual Intervention for Long Lasting Symptoms in Borderline Personality Disorder

DBT+Context
Start date: March 1, 2022
Phase: N/A
Study type: Interventional

Although borderline personality disorder (BPD) tend to the clinical remission in long-term follow-up studies, a significant subgroup of patients continues to present long lasting symptoms such as low mood, emptiness and persistent impairment in psychosocial adjustment. The prevalence of this subsample of individuals is considerably increasing last years. New interventions addressed to these individuals are need, the aim of this study is to evaluate the efficacy of a novel intervention combining dialectical behavioral therapy skills training with self-compassion and contextual-based skills for patients with long-lasting BPD.

NCT ID: NCT02465697 Completed - Clinical trials for Borderline Personality Disorders

Changes in the Brain as Borderline Patients Learn to Regulate Their Emotions

Start date: September 2011
Phase: N/A
Study type: Interventional

Borderline Personality Disorder (BPD), a prevalent psychiatric disorder found in approximately 2% to 6% of the population and 20% of hospitalized psychiatric patients, has proven quite treatment resistant. This study is designed to determine whether patients with BPD can be trained to improve their ability to regulate their emotions and whether this leads to changes in how their brans regulate emotion.

NCT ID: NCT01033708 Unknown status - Clinical trials for Posttraumatic Stress Disorders

A Randomized Control Trial of Narrative Exposure Therapy Versus Treatment as Usual in the Therapy of Borderline Personality Disorder

NET
Start date: October 2009
Phase: N/A
Study type: Interventional

Definition of the efficacy of NET compared with "treatment as usual" in the treatment of patients with complex traumatic disease (borderline personality disorder (BPD) and posttraumatic stress disorder (PTSD)) as assessed by structured clinical interviews. Furthermore, to evaluate the sleep, cortisol level and epigenetic differences in the process of the specific therapy compared to treatment as usual.